APA (7th ed.) Citation

AJ, P., S, W., JLV, M., R, M., MA, M., MR, P., . . . P, C. (2022). PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry. Cancer discovery, 12(9), 2120. https://doi.org/10.1158/2159-8290.CD-21-1671

Chicago Style (17th ed.) Citation

AJ, Patel, et al. "PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry." Cancer Discovery 12, no. 9 (2022): 2120. https://doi.org/10.1158/2159-8290.CD-21-1671.

MLA (9th ed.) Citation

AJ, Patel, et al. "PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry." Cancer Discovery, vol. 12, no. 9, 2022, p. 2120, https://doi.org/10.1158/2159-8290.CD-21-1671.